Abdel Abdel-Rahman | Cardiovascular Pharmacology | Innovative Research Award

Published on by International Popular Scientist Awards

Innovative Research Award

Abdel Abdel-Rahman
East Carolina University, United States
Abdel Abdel-Rahman
Affiliation East Carolina University
Country United States
Scopus ID 7102847207
Documents 181
Citations 3711
h-index 33
Subject Area Cardiovascular Pharmacology
Event International Popular Scientist Awards
ORCID
0000-0002-3461-2190

Abdel Abdel-Rahman  the Innovative Research Award recognizes distinguished scientific contributions in the field of cardiovascular pharmacology and related biomedical sciences. Abdel Abdel-Rahman of East Carolina University has developed an extensive scholarly portfolio that reflects sustained academic productivity, interdisciplinary collaboration, and measurable scientific impact in cardiovascular research and pharmacological sciences.[1] His publication record, citation performance, and recognized expertise in cardiovascular pharmacology position him as a notable contributor within the international scientific community.[2]

Abstract

Abdel Abdel-Rahman has contributed extensively to cardiovascular pharmacology through scholarly investigations addressing vascular physiology, autonomic regulation, pharmacodynamics, and therapeutic mechanisms associated with cardiovascular disorders. His academic output demonstrates a strong emphasis on translational biomedical research and pharmacological innovation.[1] With 181 indexed documents, 3711 citations, and an h-index of 33, his work has achieved significant scholarly visibility and international academic engagement.[2] The Innovative Research Award acknowledges these contributions within the framework of the International Popular Scientist Awards program.

Keywords

The Innovative Research Award in Cardiovascular Pharmacology recognizes pioneering contributions that advance the understanding and treatment of cardiovascular diseases through pharmacological innovation and biomedical discovery. This award celebrates researchers whose work bridges Pharmacological Research, Biomedical Sciences, and Translational Medicine to develop safer, more effective cardiovascular therapeutics. It honors excellence in innovative drug development, clinical applications, and transformative scientific research that improves global cardiovascular health outcomes.

Introduction

Cardiovascular pharmacology remains an essential scientific discipline within biomedical research due to its role in understanding cardiovascular diseases, therapeutic mechanisms, and pharmacological interventions. Research within this domain contributes to the development of treatment strategies for hypertension, vascular dysfunction, and cardiac pathophysiology.[2]

Abdel Abdel-Rahman has maintained a sustained academic presence in this field through research activities associated with East Carolina University. His work demonstrates consistent scholarly productivity and scientific engagement within cardiovascular and pharmacological sciences.[1] The International Popular Scientist Awards recognize researchers whose scientific achievements contribute meaningfully to academic advancement and interdisciplinary biomedical knowledge.

Research Profile

The research profile of Abdel Abdel-Rahman reflects extensive engagement in cardiovascular pharmacology, autonomic regulation, neuropharmacology, and vascular function research. His scientific investigations have addressed mechanisms influencing blood pressure regulation, pharmacological responses, and cardiovascular signaling pathways.[2]

Bibliometric indicators associated with his scholarly output demonstrate sustained academic visibility. According to indexed scholarly databases, his work has accumulated thousands of citations and a notable h-index, indicating both productivity and citation influence within the biomedical research community.[2]

Research Contributions

Abdel Abdel-Rahman’s scientific contributions include investigations into cardiovascular regulation, pharmacological interactions, and neurovascular signaling. His studies have explored physiological mechanisms underlying vascular control and the pharmacodynamics associated with cardiovascular therapeutics.[5]

Several publications associated with his research profile have examined experimental pharmacological models relevant to cardiovascular disease mechanisms and therapeutic responses. These contributions have enhanced understanding of autonomic modulation and vascular pharmacology within preclinical and translational research contexts.[1]

Publications

The publication portfolio of Abdel Abdel-Rahman includes peer-reviewed articles focusing on cardiovascular pharmacology and related biomedical sciences. His indexed research output demonstrates continuity in scientific productivity and interdisciplinary collaboration.[1]

Representative publications indexed within international scholarly databases have contributed to citation growth and broader academic dissemination.[2]

Research Impact

The scientific impact of Abdel Abdel-Rahman’s work is reflected through citation metrics, publication visibility, and continued relevance within cardiovascular pharmacology research. His research output has contributed to ongoing academic discussions concerning cardiovascular physiology, vascular pharmacology, and therapeutic intervention strategies.

An h-index of 33 indicates consistent citation performance across multiple scholarly works, while a citation count exceeding 3700 demonstrates sustained engagement by the international biomedical research community.[2] These indicators collectively support the scholarly significance of his research activities.

Award Suitability

The Innovative Research Award recognizes individuals demonstrating substantial scientific contributions, scholarly influence, and research advancement within their respective disciplines. Abdel Abdel-Rahman’s academic profile aligns with these criteria through sustained publication activity, recognized citation impact, and research contributions within cardiovascular pharmacology.[1]

His scientific work reflects methodological rigor, interdisciplinary relevance, and ongoing contributions to pharmacological sciences. Participation in the International Popular Scientist Awards further highlights the importance of promoting impactful biomedical research and academic excellence.[1]

Conclusion

Abdel Abdel-Rahman’s scholarly record demonstrates a sustained commitment to cardiovascular pharmacology and biomedical research. Through extensive publication activity, measurable citation influence, and interdisciplinary scientific contributions, he has established a recognized academic presence within the international research community.[2] The Innovative Research Award acknowledges these accomplishments within the broader context of scientific advancement and research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Abdel Abdel-Rahman, Author ID 7102847207. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102847207
  2. ORCID. (n.d.). ORCID profile for Abdel Abdel-Rahman.
    https://orcid.org/0000-0002-3461-2190
  3. International Popular Scientist Awards. (n.d.). Research recognition and scientific excellence initiatives.
    https://popularscientist.com/
  4. Katzung, B. G. (2021). Basic and Clinical Pharmacology. McGraw-Hill Education

Mary Imboden | Cardiovascular Health | Best Researcher Award

Published on by International Popular Scientist Awards

Dr. Mary Imboden | Cardiovascular Health | Best Researcher Award

Academician | Providence Health and Services Oregon and Southwest Washington | United States

Dr. Mary Imboden is a Principal Research Scientist at the Providence Center for Cardiovascular Analytics, Research and Data Science, where she develops and leads a portfolio of cardiovascular-related research projects while also serving as Research Fellow with the Health Enhancement Research Organization, managing national initiatives on worker well-being and health promotion. She has held leadership roles in academia, including as Chair and Associate Professor in the Department of Kinesiology at George Fox University, where she also directed employee health and fitness programs, and has taught in the Healthy Lifestyle Practitioner Certificate Program at the University of Illinois-Chicago. Her editorial contributions include serving as Co-Editor of the American Journal of Health Promotion, overseeing the “Knowing Well, Being Well” section. She has actively contributed to professional service through leadership roles with the Oregon Academy of Science, the Clinical Exercise Physiology Association, and multiple advisory boards including PAPREN, the Wellbeing Think Tank, and the Ball State University College of Health External Advisory Council. Her research expertise spans cardiorespiratory fitness, physical activity, workplace well-being, health disparities, and cardiovascular disease prevention, with numerous peer-reviewed publications in high-impact journals such as JACC, Progress in Cardiovascular Diseases, American Journal of Health Promotion, and Medicine and Science in Sports and Exercise. She has also authored widely cited workplace health promotion resources and scorecards that have shaped industry practices. Her scholarly impact includes 1,400 citations by 1,230 documents across 44 publications, with an h-index of 18. Her work is characterized by a strong focus on translating research into practice at organizational, community, and national levels, advancing evidence-based strategies that integrate health promotion, workforce well-being, and chronic disease prevention to improve both individual and population health outcomes.

Profile: Scopus | Orcid | LinkedIn | Researchgate

Featured Publications

Imboden, M. T., Koltner, E., Bryant, J., Jones, A., Swanson, R., Tam, L., & Woolf, K. (in press). Sex disparities in acute myocardial infarction diagnosis and treatment. American Journal of Cardiology.

Imboden, M. T., Gill, M., Jones, K., Ghosal, R., Gilmore, A., Johnson, A., Wilson, E., Gluckman, T. J., Ateya, M., Dai, F., Mazey, L. L., Townsend, K. A., & Wendt, S. J. Medication adherence patterns for patients with atrial fibrillation: A mixed methods study to understand patient and clinician perspectives. BMC Cardiovascular Disorders.

Li, H. F., Imboden, M. T., Wendt, S. J., Jones, L. K., Sidelnikov, E., & Gluckman, T. J. (under review). A simplified approach to atherosclerotic cardiovascular disease risk assessment. American Journal of Preventive Cardiology.

Imboden, M. T., & Moseley, K. (2025). Boosting business and health: The case for workplace physical activity. American Journal of Health Promotion, 39(7), 1082–1084.

Ablah, E., Imboden, M. T., Zendell, A., Hosking, M., Anderson, R. E., VanHoose, K., Peterson, N., Wojcik, J. R., Pronk, N. P., Harber, M., & Whitsel, L. P. (2025). Benefits of supplementing a GLP-1 type medication with physical activity. American Journal of Health Promotion, 39(7), 1088–1095.